The ability of bacterial pathogens to develop resistance against antimicrobial drugs is a key issue when caring for infected patients, especially those admitted to the intensive care unit (ICU). Antimicrobial resistance increases the risk of inadequate empirical coverage and may dramatically complicate the management of definite therapy, which often translates into worsened outcome for the most severely ill patients (Fig. 1) [1]. Nowadays, resistance rates have reached alarming levels, notably in ICU-acquired Gram-negative bacilli (GNB), and current trends suggest that the magnitude of the problem will continue to rise [2]. In this context, understanding resistance mechanisms may serve as a prerequisite to optimize antimicrobial use in daily practice and to appraise how reducing antibiotic consumption could help control the spread of multidrug-resistant (MDR) pathogens.
×
…
Anzeige
Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten